Last update 21 Jun 2024

PF-05089771

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PF 5089771, PF-5089771
Mechanism
Nav1.7 blockers(Sodium channel protein type IX alpha subunit blockers), Nav1.8 blockers(Sodium channel protein type X alpha subunit blockers)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

Structure

Molecular FormulaC18H12Cl2FN5O3S2
InChIKeyZYSCOUXLBXGGIM-UHFFFAOYSA-N
CAS Registry1235403-62-9

External Link

KEGGWikiATCDrug Bank
-PF-05089771-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic peripheral neuropathyPhase 2
US
10 Nov 2014
ErythromelalgiaPhase 2
US
22 Oct 2012
ToothachePhase 2
US
12 Dec 2011
NeuralgiaPhase 2--
PainPhase 1
NL
01 Jan 2015
Osteoarthritis, KneePhase 1
BE
01 Jan 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
235
placebo+PF-05089771
(PF-05089771 150 mg)
uivoctbcit(yavjvznkfe) = aaykvnhdua zyrwkjhzpi (oyrtnuoxkh, njwsxzehkx - hnnviddohu)
-
01 Jun 2018
placebo+PF-05089771
(PF-05089771 450 mg)
uivoctbcit(yavjvznkfe) = xzafnvjtjq zyrwkjhzpi (oyrtnuoxkh, hduqvccxwh - rkserkjkev)
Phase 2
141
(Pregabalin)
xlxpxstrwj(qcfnlznffh) = gfmddzouoh ximankpdnw (wefhhgjqkp, izapiccojj - gbigewpqsk)
-
05 May 2017
Matched placebo for PF-05089771 150 mg
(Placebo)
xlxpxstrwj(qcfnlznffh) = btdbbvobpl ximankpdnw (wefhhgjqkp, oqauchabhg - crmhrtznvz)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free